The trademark APLANTIS was filed by DENK PHARMA GmbH & Co. KG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on June 12, 2018, and received undefined oppositions.
There are undefined oppositions were filed:
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Deletion of the representative of the trademark registration was recorded on May 14, 2023. Appointment and Replacement of representative of the trademark registration was recorded on May 15, 2023. Requests for conversion of an EUTM application into a national trade mark application of the trademark registration was recorded on November 29, 2023.
The Appeal with reference B R2605/2019-4 was Opposition allowed according to Article 8(1)(b) EUTMR with decision issued on June 22, 2020 by the EUIPO. The Opposition with reference B 003060121 was refused according to Article 8(1)(b) EUTMR with decision issued on July 3, 2023 by the EUIPO. The Opposition with reference B 003063638 was rejected according to Article 8(1)(b) EUTMR with decision issued on January 8, 2020 by the EUIPO. The Opposition with reference B 003063967 was rejected according to Article 8(1)(b) EUTMR with decision issued on October 21, 2019 by the EUIPO.